Concentra Group Holdings Parent, Inc. (CON)

Healthcare · NYQ

$35.21-0.38% today

Price as at 30 Sept 2026, 17:13 UTC. Quotes are delayed.

Fundamentals

Market cap$4.04B
P/E ratio22.7
Dividend yield0.79%
Revenue growth (YoY)+13.7%
Profit margin8.0%
Return on equity47.0%
52-week range$18.55 to $36.71

Valuation and ratings

Fair value estimate$53.51
Upside to fair value+52.0%
Analyst target (mean)$33.38
Analyst range$28.00 to $37.00
Analysts with price targets8
Consensus viewstrong buy
Moat score50/100
Overall rating63/100, good quality

Fair value: $53.51 (+52.0%), see how we got there

Concentra Group Holdings Parent, Inc. trades at $35.21, which is 52% below the $53.51 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.

Our moat model scores it 50 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

It changes hands at 22.7 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.

CON dividend history

Dividend yield0.79%
Paid, trailing 12 months$0.252 per share
Most recent payment$0.063, ex 20 Aug 2026
Consecutive years of growth1
Consecutive years paid2

Dividends per share by year

YearTotal per sharePayments
2026 (year to date)$0.1893
2025$0.2524
2024$0.0631

Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.

CON earnings and analyst estimates

EPS estimate, next year$1.69
Expected EPS growth+11.6%
Expected revenue growth+5.9%

Recommendation mix, 9 published ratings

9 buy0 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

Industry: Medical Care FacilitiesEmployees: 9,967HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

CON passes 3 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Super investor ownership

8 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

CON peers

The largest companies in the same industry (Medical Care Facilities), then in the same sector.

Every healthcare company we cover is on the Healthcare hub.

Common questions

Is Concentra Group Holdings Parent, Inc. (CON) undervalued?

Against our fair value estimate of $53.51, CON at $35.21 is 52% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Which funds own CON?

8 of the institutions we track reported a position in CON in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.

What is CON's P/E ratio?

CON trades at 22.7 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.

Does Concentra Group Holdings Parent, Inc. (CON) pay a dividend?

Yes. Concentra Group Holdings Parent, Inc. yields 0.79% at the current share price. It has paid $0.252 per share over the trailing twelve months. It has paid a dividend in each of the last 2 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.

Where does SteadyShares get its CON data?

Fundamentals for CON come from company filings and exchange data, as listed on NYQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 17:13 UTC and is delayed. Our data quality score for this company is 96/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for CON, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.